Cite

HARVARD Citation

    Willsmore, Z. et al. (2021). Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action. European journal of immunology. 51 (3), pp. 544-556. [Online]. 
  
Back to record